The table below shows CORCEPT THERAPEUTICS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$164.90M
$207.64M
$194.43M
$157.21M
$182.55M
$163.80M
Cost of revenue
$2.88M
$4.60M
$3.43M
$2.40M
$2.87M
$2.52M
Gross profit
-
-
-
-
-
-
R&D
$66.27M
$68.85M
$60.47M
$60.73M
$59.34M
$58.74M
CORT annual revenue (10-K history)
CORCEPT THERAPEUTICS INC reported annual revenue of $761.41M for fiscal year 2025. That is up 12.8% from $675.04M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $81.32M (FY 2016) to $761.41M. Figures come from the company's audited annual reports as filed with the SEC.
